9:00 AM- 11:00 AM

CNS Summit 2017 Leadership Council
and Program Committee Meeting
-- BY INVITATION ONLY --

11:00 AM- 12:00 PM

Clinical Trials of the Future:
Domain Core Team Meetings
-- BY INVITATION ONLY --

12:00 PM- 1:00 PM

Lunch
(On Own)

1:00 PM- 3:30 PM

Parallel Sessions:

Session 1: Clinical Research as Care Option
          Tina Moen, Deputy Chief Health Officer, IBM Watson Health
          Steve Rosenberg, SVP & GM, Oracle Health
          John Reites, Chief Product Officer, THREAD
          Drew Schiller, CEO & Co-Founder, Validic
          Tom Zoda, EVP & General Manager, Clinical Development, CNS, INC Research/inVentive Health
          Reed Tuckson, Managing Director, Tuckson Health Connections
          Jane Shen, President, Board of Directors, Wake Forest Healthcare Venture
          Moderator: Jeremy Sohn, VP, Digital Business Development, Novartis

Session 2: Thunder Pain and Lightning Round
          Howard Hassman, Hassman Research Institute (HRI)
          Larry Ereshefsky, HRI, Follow the Molecule
          Johan den Boer, PRA
          Mike Royal, Liquidia Technologies
          Krista Hill, HRI
          Jay Kranzler, Perception Biosciences

Session 3: Technology and the Future of Cognition
          Paul Maruff, Chief Science Officer, Cogstate
          Richard Keefe, Co-Founder & CEO, NeuroCog Trials
          Francesca Cormack, Director of Research & Innovation, Cambridge Cognition
          Tom Insel, Co-Founder & President, Mindstrong
          Philip Harvey, Professor of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine
          Luca Pani, University of Miami, former CHMP & SAWP Member, European Medicines Agency
          Moderator: William Jacobson

3:30 PM- 4:30 PM

SPECIAL RECEPTION
-- BY INVITATION ONLY --

4:30 PM- 5:00 PM

CNS Summit 2017 New Participant Reception

5:00 pm- 6:30 pm

CNS Summit 2017 Welcome Reception

7:00 AM- 7:45 AM

Breakfast

8:00 AM- 12:00 PM

Welcome Remarks

Introductory Address
Amir Kalali
Chief Curator, CNS Summit

CNS Summit 2017 Keynote Session
David Bach, Founder & President, Platypus Institute
Adam Gazzaley, Co-Founder, Chief Science Advisor, Akili Interactive Labs
Eddie Martucci, Co-Founder & CEO, Akili Interactive Labs
Daphne Zohar, Founder & CEO, PureTech Health
Tom Insel, Co-Founder & President, Mindstrong
Milind Kamkolkar, Chief Data Officer, Sanofi
Ron Cohen, President & CEO, Acorda Therapeutics
Melinda Richter, Global Head, JLABS
John Nosta, Founder, NostaLabs
Mike Rea, CEO, IDEA Pharma
Jane Metcalfe, Founder, WIRED Magazine, Neo.Life
Nick Adkins, Founder, Pinksocks, Healthcare Evangelist

CNS Summit 2017 Innovation Index

12:00 pm- 1:00 pm

Innovation Showcase
(Lunch Provided)
Michelle Longmire, Co-Founder & CEO, Medable
Leila Pirhaji, Co-Founder & CEO, ReviveMed
Ardy Arianpour, Co-Founder & CEO, [stealth company]
Wout Brusselaers, CEO, Deep 6
Moderated By Spyros Papapetropoulos, Cavion and Georgia Mitsi, Sunovion

1:00 pm- 1:30 pm

Solution Showcase
Yonatan Dolan, Business Development Intel ® Pharma Analytics Platform, Intel
Chen Admati, Head of Intel ® Pharma Analytics Platform, Intel

1:30 pm- 3:30 pm

CNS Summit Parallel Sessions:


Session 1: Site of the Future
          David Walling, CEO, Collaborative Neuroscience Network
          Sean Stanton, COO, Global Clinical Research, Bioclinica
          Ellyn Getz, Sr Manager, Development and Community Engagement, CISCRP
          Elan Cohen, Investigator, Hassman Research Group
          Christian Burns, President & Co-founder, ClinEdge & BTC
          Bonnie Segal, Vice President & Co-Founder, Segal Trials
          Nelson Rutrick, CEO, CluePoints
          Patrick Hughes, Chief Commercial Officer, CluePoints
          Raymond Nomizu, Co-founder and Co-CEO, Clinical Research IO

Session 2: Revolutionizing Outcome Measures in Alzheimer's Trials
          John Harrison, Alzheimer Center, VUmc, Amsterdam
          Maria Carrillo, Chief Science Officer, Alzheimer's Association
          Charles Wilcox, Executive Director, Pharmacology Research Institute
          Cara Pendergrass, Vice President, Clinical Operations, Bracket
          Michael Gold, Vice-President, Development Neurosciences, AbbVie
          Bill Holt, Executive Director, Neuroscience, PRA Health Sciences

Session 3: Digital Biomarkers: How to Implement
          Deborah Kilpatrick, CEO, Evidation
          Bakul Patel, Digital Health, U.S. Food & Drug Administration (FDA)
          Larsson Omberg, VP Systems Biology, SAGE Bionetworks
          Adam Hanina, CEO, AiCure
          Eddie Martucci, CEO, Akili Interactive Labs
          Donald McLaren, Clinical Scientist, Biospective
          Andrea Coravos, Co-Founder and CEO, Elektra Labs
          Moderator: Brad Miller, Sr. Managing Director, Lilly

Session 4: Remote Research Workshop
          John Reites, Chief Product Officer, THREAD
          Penny Randall, VP, Head, CNS Center of Excellence, IQVIA
          Tomasz Sablinski, Co-founder & CEO, Transparency Life Sciences

Session 5: Neuroscience Session
          Harry Tracy, Founder & President, NI Research
          Kenneth Koblan, Head,Global Translational Medicine & Early Development - TMED, Sunovion
          Margaretta Nyilas, SVP, Clinical Management & Business Operations, Otsuka
          Kim Vanover, Senior Vice President, Clinical Development, Intra-Cellular Therapies

3:30 pm- 5:00 pm

One-to-One Networking Sessions

5:00 pm- 7:00 pm

Evening Reception, Posters & Exhibits

7:00 AM- 7:45 AM

Breakfast

8:00 AM - 12:00 PM

Welcome Remarks

CNS Summit 2017 Keynote Session
Bill Carson, President & CEO, Otsuka
George Savage, Co-Founder & CMO, Proteus Digital Health
Corey McCann, CEO, Pear Therapeutics
Bakul Patel, Associate Director of Digital Health, FDA
Joseph Owens, X, (Google)
Elliot Menschik, Life Sciences, Amazon
Larsson Omberg, SAGE Bionetworks
Mikkel Hansen, Chief Medical Officer, Philips
Jennifer Goldsack, CTTI
Glen de Vries, President, Medidata
Cynthia Verst, President, IQVIA
Brent Saunders, CEO, Allergan
David Nicholson, Chief R&D Officer, Allergan
Armin Szegedi, VP Clinical Development, Allergan

CNS Summit 2017 Innovation Index

12:00 pm- 1:00 pm

Innovation Showcase
(Lunch Provided)
Michael Hufford, CEO, LyGenesis
Niousha Bolandzadeh, Founder & CEO, Brite Health
Joseph Geraci, Founder, NetraMark
Moderated By Spyros Papapetropoulos, Cavion and Georgia Mitsi, Sunovion

1:00 pm- 1:30 pm

Solution Showcase
Al O. Pacino, President, BlueCloud® by HealthCarePoint

1:30 pm- 3:30 pm

CNS Summit Parallel Sessions:


Session 1: Drug Development Nirvana:
Site Operations Impact on Life Sciences
          Tim Peters-Strickland, Senior Director, Global Clinical Development, Otsuka
          Jacob LaPorte, Head of Digital Development, Novartis
          Melissa Holbrook, Vice President, Site and Patient Networks, IQVIA
          Lori Wright, CEO, Evolution Research Group
          Sean Walsh, Chief Development Officer, Raleigh Neurology Associates
          Rishi Kakar, CSO, Segal Trials
          David Daniel, SVP & CMO, Bracket
          Christian Burns, President, ClinEdge
          Moderated by Lisa LaLuna, SVP, ePharmaSolutions

Session 2: Optimizing Mobile Technology for Data Capture in Clinical Trials
          Sohini Chowdhury, Deputy CEO, Michael J. Fox Foundation
          Jennifer Goldsack, Clinical Trials Transformation Initiative (CTTI)
          Barry Peterson, Scientific Consultant, Philips Healthcare
          John Reites, Chief Product Officer, THREAD
          Kaveeta Vasisht, U.S. Food & Drug Administration (FDA)
          Moderator: Jessie Bakker, Sr. Manager, Clinical Affairs, Philips Healthcare

Session 3: Design Thinking Your Way Out of the Box: From Inspiration to Implementation
          Bill Evans, SVP Innovation, Ximedica
          Andrew Chacko, Principal, ChackoMD

Session 4: How AI and Machine Learning are Powering Better Patient Care from Drug Discovery to the Doctor’s Office
          Rhoda Au, Professor of Anatomy & Neurobiology, Boston University Schools of Medicine
          CJ Hameed, Director, Clinical Informatics Lead, Pfizer
          Charles Venuto, Assistant Professor of Neurology, University of Rochester Medical Center
          Moderator: Diane Wuest, Precision Medicine Lead, GNS Healthcare

Session 5: Neuroscience Session
          Dimitri Gridoriadis, Chief Research Officer, Neurocrine
          Ajay Verma, Chief Medical Officer, United Neuroscience
          Roger Bullock, Chief Medical Officer, Oryzon Genomics
          Cedric O’Gorman, SVP, Clinical Development & Medical Affairs, Axsome Therapeutics
          Gerald Commissiong, President & CEO, Amarantus Bioscience

3:30 pm- 5:00 pm

One-to-One Networking Sessions

5:00 pm- 7:00 pm

Evening Reception, Posters & Exhibits

7:30 am- 8:15 am

Breakfast

8:30 am- 12:00 pm

Welcome Remarks

CNS Summit 2017 Keynote Session

Be the Catalyst of Change for Patient Advocacy and Awareness in Drug Development: Turning Data into Insight
Sohini Chowdhury, Deputy CEO, Michael J. Fox Foundation
Chris Snyder, Director, American Cancer Society
Susan Manoff, Executive Director, Office of the Chief Patient Officer, Merck
Patricia Roselle, Associate Director, Patient Networks, Sanofi
T. J. Sharpe, Patient Advocate
Carlos A. Larrauri, Board of Directors for NAMI Miami-Dade
Lissa Poincenot, Patient Advocate
Ken Getz, Founder and Chairman; CISCRP
Jennifer Byrne, Founder, Greater Gift
Shishuka Malhotra, MD, Founder and Medical Director, NeuroBehavorial Clinical Research
Lisa La Luna, SVP, Corporate Development & Implementation, ePharmaSolutions
Bonnie Segal, Vice President and Co-Founder, Segal Trials

12:00 pm

Adjourn